The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

12 articles for RB Diebold


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Towards the next generation of dual Bcl-2/Bcl-xL inhibitors.EBI
Astrazeneca
Discovery and Optimization of Quinolinone Derivatives as Potent, Selective, and Orally Bioavailable Mutant Isocitrate Dehydrogenase 1 (mIDH1) Inhibitors.EBI
Forma Therapeutics
Structure-Based Design and Identification of FT-2102 (Olutasidenib), a Potent Mutant-Selective IDH1 Inhibitor.EBI
Forma Therapeutics
Mitigation of cardiovascular toxicity in a series of CSF-1R inhibitors, and the identification of AZD7507.EBI
Astrazeneca
Modulators of sphingosine phosphate receptorsBDB
The Scripps Research Institute
Fused pyrimidine compound or salt thereofBDB
Taiho Pharmaceutical
Substituted indazole derivatives active as kinase inhibitorsBDB
Nerviano Medical Sciences
1,3 substituted azetidine PDE10 inhibitorsBDB
Merck Sharp & Dohme
4-amino-6-alkyloxy-2-alkylthiopyrimidine derivatives as novel non-nucleoside agonists for the adenosine A1 receptor.BDB
Universit�� Di Napoli Federico Ii
Structural similarities between thiamin-binding protein and thiaminase-I suggest a common ancestor.BDB
Cornell University
Cloning of cDNAs encoding the human gamma-aminobutyric acid type A receptor alpha 6 subunit and characterization of the pharmacology of alpha 6-containing receptors.BDB
Merck Sharp & Dohme Research Laboratories
The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinase.BDB
Merck Research Laboratories